Novozymes A/S (NVZMF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Novozymes A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
326.24
Weak
WeakModerateStrong
P/B Ratio
15.57
Weak
WeakModerateStrong
Earnings Yield
0.34%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
5.37%
Weak
WeakModerateStrong
Operating Margin
21.23%
Strong
WeakModerateStrong
Net Profit Margin
14.04%
Moderate
WeakModerateStrong
Growth Indicators
2025Revenue Growth
8.53%
Moderate
WeakModerateStrong
Net Income Growth
90.98%
Strong
WeakModerateStrong
EPS Growth
86.57%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
0.72
Weak
WeakModerateStrong
Quick Ratio
0.44
Weak
WeakModerateStrong
Asset Turnover
0.25x
Weak
WeakModerateStrong
Inventory Turnover
2.48x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.44%
Weak
WeakModerateStrong
EV / Free Cash Flow
254.73x
Weak
WeakModerateStrong
Net Debt / EBITDA
16.00x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.842
Weak
WeakModerateStrong
Return on Invested Capital
2.63%
Weak
WeakModerateStrong
Cash Conversion Cycle
143.37 days
Weak
WeakModerateStrong
Fortress screener guardrails
0/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for NVZMF.
View Financial Statements